Cancer patient selection for administration of therapeutic agents using mass spectral analysis

Details for Australian Patent Application No. 2011219069 (hide)

Owner Biodesix, Inc.

Inventors Grigorieva, Julia; Roder, Heinrich; Tsypin, Maxim

Agent Spruson & Ferguson

Pub. Number AU-A-2011219069

PCT Pub. Number WO2011/106084

Priority 61/338,938 24.02.10 US

Filing date 22 February 2011

Wipo publication date 1 September 2011

International Classifications

G01N 30/72 Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography

G01N 33/48 Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

Event Publications

13 September 2012 PCT application entered the National Phase

  PCT publication WO2011/106084 Priority application(s): WO2011/106084

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011219091-Method and device for treatment of water

2011219065-Fastener back-out erosion devices and systems